Beckley Psytech

About Beckley Psytech

Beckley Psytech is dedicated to pioneering the next generation of mental health treatments. Their mission is to develop effective, rapid-acting, and accessible medicines for individuals living with mental health conditions, addressing the significant global unmet need in this area.

Products & Services

BPL-003 (Intranasal Mebufotenin Benzoate):An investigational psychedelic-based compound for treatment-resistant depression, showing rapid, robust, and lasting antidepressant effects with options for single or two-dose regimens.

Next-Generation Compounds:Psychedelic-based medicines designed to be administered in short clinic visits, well-tolerated, and capable of delivering rapid and lasting treatment effects.

Specialties

Psychedelic-based Treatments Rapid-Acting Mental Health Medicines Treatment-Resistant Depression

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Equity Investment T: - FT: Equity Investment	A: 50000000 MR: - FA: 50 million dollars FAN: 50000000	D: 2024-01-08 FD: 2024-01-08	1 investors
2	RT: Strategic Investment T: - FT: Strategic Investment	A: 50000000 MR: - FA: 50 million FAN: 50000000	D: 2024-01-08 FD: 2024-01-08	1 investors

Equity Investment Latest

2024-01-08

$50.0M

1 investor (Pro only)

Strategic Investment 2024-01-08

$50.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Amanda Feilding

Founder and Director of the Beckley Foundation

C

Cosmo Feilding Mellen

Founder

Recent News

Beckley Psytech Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised